Ken Griffin’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,313
| Closed | -$38.7K | – | 14089 |
|
|
2025
Q3 | $41K | Buy |
+1,313
| New | +$41.4K | ﹤0.01% | 12284 |
|
|
2025
Q2 | – | Sell |
-1,385
| Closed | -$27.8K | – | 15125 |
|
|
2025
Q1 | $23.7K | Buy |
+1,385
| New | +$32.8K | ﹤0.01% | 13022 |
|
|
2024
Q4 | – | Sell |
-472
| Closed | -$15.6K | – | 15403 |
|
|
2024
Q3 | $15.6K | Hold |
472
| – | – | ﹤0.01% | 12964 |
|
|
2024
Q2 | $29.3K | Buy |
+472
| New | +$27.5K | ﹤0.01% | 12300 |
|
|
2024
Q1 | – | Sell |
-217
| Closed | -$13.9K | – | 15446 |
|
|
2023
Q4 | $13.9K | Buy |
+217
| New | +$15.5K | ﹤0.01% | 12903 |
|
|
2023
Q3 | – | Sell |
-251
| Closed | -$36.3K | – | 15121 |
|
|
2023
Q2 | $36.3K | Buy |
251
+103
| +70% | +$15K | ﹤0.01% | 12151 |
|
|
2023
Q1 | $20.9K | Buy |
+148
| New | +$22.9K | ﹤0.01% | 13039 |
|
|
2022
Q1 | – | Sell |
-126
| Closed | -$21.8K | – | 14589 |
|
|
2021
Q4 | $27K | Buy |
126
+8
| +7% | +$2.27K | ﹤0.01% | 13511 |
|
|
2021
Q3 | $38K | Sell |
118
-15
| -11% | -$5.28K | ﹤0.01% | 13490 |
|
|
2021
Q2 | $58K | Buy |
133
+36
| +37% | +$18K | ﹤0.01% | 13273 |
|
|
2021
Q1 | $54K | Buy |
+97
| New | +$70K | ﹤0.01% | 12872 |
|
|
2020
Q4 | – | Sell |
-349
| Closed | -$173K | – | 11531 |
|
|
2020
Q3 | $105K | Buy |
349
+282
| +421% | +$97.9K | ﹤0.01% | 9247 |
|
|
2020
Q2 | $22K | Buy |
+67
| New | +$15.3K | ﹤0.01% | 9535 |
|
|
2017
Q1 | – | Sell |
-95
| Closed | -$99K | – | 8053 |
|
|
2016
Q4 | $99K | Buy |
+95
| New | +$98.2K | ﹤0.01% | 6682 |
|
|
2016
Q2 | – | Sell |
-88
| Closed | -$153K | – | 7415 |
|
|
2016
Q1 | $153K | Buy |
+88
| New | +$140K | ﹤0.01% | 5817 |
|
|
2015
Q2 | – | Sell |
-309
| Closed | -$892K | – | 9104 |
|
|
2015
Q1 | $892K | Sell |
309
-4
| -1% | -$11.1K | ﹤0.01% | 4074 |
|
|
2014
Q4 | $823K | Buy |
313
+65
| +26% | +$168K | ﹤0.01% | 4009 |
|
|
2014
Q3 | $680K | Buy |
248
+51
| +26% | +$166K | ﹤0.01% | 4206 |
|
|
2014
Q2 | $679K | Buy |
197
+77
| +64% | +$274K | ﹤0.01% | 3980 |
|
|
2014
Q1 | $436K | Buy |
120
+58
| +94% | +$228K | ﹤0.01% | 4543 |
|
|
2013
Q4 | $233K | Buy |
+62
| New | +$223K | ﹤0.01% | 4866 |
|
Other funds holding TRIB
HAIM
YAG
WN
VF
MAWA
IWA
BCM
Ken Griffin's TRIB Position: Q4 2025 in Review
Ken Griffin sold out of Trinity Biotech (TRIB) in Q4 2025, closing a stake of 1,313 shares — an estimated $38.7K sold.
Ken Griffin first reported a position in TRIB in Q4 2013 and held it in 21 quarters. The position peaked at $892K in Q1 2015. 25 funds tracked by Wall St. Rank hold TRIB as of Q4 2025.
- Ken Griffin reported no remaining Trinity Biotech position as of Q4 2025 after selling out during the quarter.
- Ken Griffin sold 1,313 Trinity Biotech shares in Q4 2025, an estimated $38.7K.
- Ken Griffin first reported a position in Trinity Biotech in Q4 2013 and held it in 21 quarters.
- Ken Griffin's Trinity Biotech position peaked at $892K in Q1 2015.
- 25 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.